Add BrightSurf on Google Email

Medical College of Georgia at Augusta University


Finding about classic suppressor of immunity points toward new therapies for bad infections

Researchers have discovered that indoleamine 2,3-dioxigenase (IDO) can promote inflammation in response to infection, potentially leading to new therapeutic targets. By manipulating IDO's activity, scientists may be able to fine-tune the immune response and reduce cytokine storms associated with severe infections.

SourceMedical College of Georgia at Augusta University·JournalMolecular and Cellular Biology·DateJan 7, 2014

STING may take the bite out of autoimmune diseases like arthritis, Type 1 diabetes

Researchers discover STING's critical role in treating autoimmune diseases by evoking expression of enzyme IDO, which blocks immune attack on healthy body constituents. Mice with STING deficiency had no response to DNA nanoparticles, highlighting the protein's essential role in recognizing the molecule that senses DNA.

SourceMedical College of Georgia at Augusta University·JournalThe Journal of Immunology·DateSep 9, 2013

Polycystic ovary syndrome puts glucose control in double jeopardy

Research shows PCOS affects both insulin and non-insulin approaches to glucose control, with declines in non-insulin activity seen in women with high insulin resistance. The study found visceral fat predicted difficulty controlling glucose via insulin, while subcutaneous fat was linked to regulation by non-insulin means.

SourceMedical College of Georgia at Augusta University·JournalThe Journal of Clinical Endocrinology & Metabolism·DateMar 13, 2013